Clark WS - Search Results

1

Early progression of disease in HIV-infected infants with thymus dysfunction.

Kourtis AP, Ibegbu C, Nahmias AJ, Lee FK, Clark WS, Sawyer MK, Nesheim S. Kourtis AP, et al. Among authors: clark ws. N Engl J Med. 1996 Nov 7;335(19):1431-6. doi: 10.1056/NEJM199611073351904. N Engl J Med. 1996. PMID: 8875920 Free article.

2

Thymic dysfunction and time of infection predict mortality in human immunodeficiency virus-infected infants. CDC Perinatal AIDS Collaborative Transmission Study Group.

Nahmias AJ, Clark WS, Kourtis AP, Lee FK, Cotsonis G, Ibegbu C, Thea D, Palumbo P, Vink P, Simonds RJ, Nesheim SR. Nahmias AJ, et al. Among authors: clark ws. J Infect Dis. 1998 Sep;178(3):680-5. doi: 10.1086/515368. J Infect Dis. 1998. PMID: 9728535

3

Experience with routine voluntary perinatal human immunodeficiency virus testing in an inner city hospital.

Henderson SL, Lindsay MK, Higgins JE, Clark WS, Bulterys M, Nesheim SR. Henderson SL, et al. Among authors: clark ws. Pediatr Infect Dis J. 2001 Nov;20(11):1090-2. doi: 10.1097/00006454-200111000-00019. Pediatr Infect Dis J. 2001. PMID: 11734720

4

Statistical analysis of the stages of HIV infection using a Markov model.

Longini IM Jr, Clark WS, Byers RH, Ward JW, Darrow WW, Lemp GF, Hethcote HW. Longini IM Jr, et al. Among authors: clark ws. Stat Med. 1989 Jul;8(7):831-43. doi: 10.1002/sim.4780080708. Stat Med. 1989. PMID: 2772443

5

Effect of routine use of therapy in slowing the clinical course of human immunodeficiency virus (HIV) infection in a population-based cohort.

Longini IM Jr, Clark WS, Karon JM. Longini IM Jr, et al. Among authors: clark ws. Am J Epidemiol. 1993 Jun 1;137(11):1229-40. doi: 10.1093/oxfordjournals.aje.a116625. Am J Epidemiol. 1993. PMID: 8100682

6

The dynamics of CD4+ T-lymphocyte decline in HIV-infected individuals: a Markov modeling approach.

Longini IM Jr, Clark WS, Gardner LI, Brundage JF. Longini IM Jr, et al. Among authors: clark ws. J Acquir Immune Defic Syndr (1988). 1991;4(11):1141-7. J Acquir Immune Defic Syndr (1988). 1991. PMID: 1684387

7

Etiology of esophageal disease in human immunodeficiency virus-infected patients who fail antifungal therapy.

Wilcox CM, Straub RF, Alexander LN, Clark WS. Wilcox CM, et al. Among authors: clark ws. Am J Med. 1996 Dec;101(6):599-604. doi: 10.1016/s0002-9343(96)00303-8. Am J Med. 1996. PMID: 9003106

8

Esophageal ulceration in human immunodeficiency virus infection. Causes, response to therapy, and long-term outcome.

Wilcox CM, Schwartz DA, Clark WS. Wilcox CM, et al. Among authors: clark ws. Ann Intern Med. 1995 Jul 15;123(2):143-9. doi: 10.7326/0003-4819-123-2-199507150-00010. Ann Intern Med. 1995. PMID: 7778827

9

Fluconazole compared with endoscopy for human immunodeficiency virus-infected patients with esophageal symptoms.

Wilcox CM, Alexander LN, Clark WS, Thompson SE 3rd. Wilcox CM, et al. Among authors: clark ws. Gastroenterology. 1996 Jun;110(6):1803-9. doi: 10.1053/gast.1996.v110.pm8964406. Gastroenterology. 1996. PMID: 8964406 Clinical Trial.

10

Prospective evaluation of oropharyngeal findings in human immunodeficiency virus-infected patients with esophageal ulceration.

Wilcox CM, Straub RF, Clark WS. Wilcox CM, et al. Among authors: clark ws. Am J Gastroenterol. 1995 Nov;90(11):1938-41. Am J Gastroenterol. 1995. PMID: 7484995

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters